Amylyx is a high-risk biotech targeting rare diseases with strong cash reserves. Key trials soon may drive a 40% stock upside.

Some staff members at the U.S. Federal Trade Commission have raised concerns about a planned workshop by the agency on what ...

Verastem's FDA approval for KRAS-mutant LGSOC, strong pipeline, and catalysts signal growth potential. Click here to read an ...

Last month, Fox News cited an anonymous source to report that doctors at Children’s Hospital Colorado are the subject of a U.S. Department of Justice criminal investigation tied to gender-affirming ...

Learn about the APPSC Forest Beat Officer Syllabus 2025, including subject-wise topics, exam pattern, preparation tips & more ...

Estrogen plays an important role in keeping bones healthy. Now, researchers investigated how membrane-initiated estrogen ...

Colin Wright A New Paper Reveals Devastating Harms of Cross-Sex Hormones Male use of estrogen is associated with a range of diseases and health complications.

CVS Caremark will stop covering Eli Lilly’s Zepbound. Wegovy, the GLP-1 medication to treat obesity from Lilly competitor ...

Yet greater awareness of sleep deprivation’s consequences hasn’t translated into a better-rested populace. Data from the CDC ...

Overview of Medical Aesthetics MarketThe global Medical Aesthetics Market is valued at USD 38 Billion in 2024 and is ...

Amycretin, a new weight-loss treatment from Novo Nordisk, combines two hunger hormones, helping participants lose nearly one-quarter of their body weight in early trials.